Eric LegrosDeputy Vice-President, Reefer Department
After a successful Merchant Marine officer career, Eric Legros joined CMA CGM Group in 1993 as a Ship Manager. Eric Legros was twice expatriated, once in Singapore in 1997 for 3 years in charge of Operations in South East Asia and once in Honk Kong in 2007 for 3 years in charge of North and Central China commercial developments. Back in the CMA CGM Head Office, he took over several positions as Trade Manager or Line Manager in Asia to Med / Latin America Departments. Now in charge of the worldwide refrigerated cargo transportation Department at CMA CGM HQ since 2010, he supervises a team of 120 experts worldwide. CMA CGM’s Reefer Department always innovates to offer new transport solutions for refrigerated goods in all sectors : Aquaviva, Reeflex, Controlled Atmosphere... and replies diligently to requirements of its customers.
12:25 PM Pharma SEA
Transportation of medicinal products is complex and challenging process requiring special attention and perfect coordination between all actors involved in supply chain. To choose reliable service provider is a key factor to make it a success. Since 2008 CMA CGM Group developed Pharma Procedure and keep growing its expertise year after year. With a Reefer fleet of 354 000 TEUs, which benefits from the latest technological innovations, the Group can provide full tracking of containers, 24/7 thanks to its reefers team of experts present in more than 85 countries. Anticipating customers’ needs CMA CGM already offers transportation matching about all requirements of Good Distribution Practice (GDP). Very well structured to match pharmaceutical industry requirements, putting in place strict procedures, CMA CGM Group is one of the most advanced shipping lines in terms of GDP recommendations deployments.
What you will learn:
• Main challenges related to maritime industry and possible solutions
• SOP/ co-ordination between stakeholders (terminals, depots, operational teams etc)
• Track and trace option for containers. Main benefits
• Pharma market trends today. What will happen tomorrow should the trend continue